1. Home
  2. OKTA vs ZBH Comparison

OKTA vs ZBH Comparison

Compare OKTA & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Okta Inc.

OKTA

Okta Inc.

HOLD

Current Price

$85.82

Market Cap

15.2B

Sector

Technology

ML Signal

HOLD

Logo Zimmer Biomet Holdings Inc.

ZBH

Zimmer Biomet Holdings Inc.

HOLD

Current Price

$94.23

Market Cap

19.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OKTA
ZBH
Founded
2009
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2B
19.9B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
OKTA
ZBH
Price
$85.82
$94.23
Analyst Decision
Buy
Buy
Analyst Count
39
19
Target Price
$116.22
$108.56
AVG Volume (30 Days)
2.9M
2.1M
Earning Date
12-02-2025
11-05-2025
Dividend Yield
N/A
1.02%
EPS Growth
N/A
N/A
EPS
1.08
4.03
Revenue
$2,840,000,000.00
$8,010,900,000.00
Revenue This Year
$12.76
$8.20
Revenue Next Year
$9.34
$5.92
P/E Ratio
$79.89
$23.38
Revenue Growth
12.12
5.47
52 Week Low
$75.05
$85.33
52 Week High
$127.57
$114.44

Technical Indicators

Market Signals
Indicator
OKTA
ZBH
Relative Strength Index (RSI) 55.88 49.85
Support Level $75.05 $92.14
Resistance Level $88.02 $98.34
Average True Range (ATR) 2.97 1.99
MACD 0.91 0.49
Stochastic Oscillator 83.04 58.27

Price Performance

Historical Comparison
OKTA
ZBH

About OKTA Okta Inc.

Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.

About ZBH Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Share on Social Networks: